The landscape of targets and lead molecules for remyelination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The landscape of targets and lead molecules for remyelination

Published:2022-08-22 Issue:9 Volume:18 Page:925-933
ISSN:1552-4450
Container-title:Nature Chemical Biology
language:en
Short-container-title:Nat Chem Biol

Author:

Caprariello Andrew V.^ORCID,Adams Drew J.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke

G. Harold and Leila Y. Mathers Foundation

Edward Mallinckrodt, Jr. Foundation

Conrad N. Hilton Foundation

National Multiple Sclerosis Society

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

https://www.nature.com/articles/s41589-022-01115-2.pdf

Reference100 articles.

1. Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C. & Stankoff, B. Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol. 19, 678–688 (2020).

2. Cunniffe, N. & Coles, A. Promoting remyelination in multiple sclerosis. J. Neurol. 268, 30–44 (2021).

3. Fancy, S. P. et al. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp. Neurol. 225, 18–23 (2010).

4. Hoftberger, R. & Lassmann, H. Inflammatory demyelinating diseases of the central nervous system. Handb. Clin. Neurol. 145, 263–283 (2017).

5. Lin, W., Harding, H. P., Ron, D. & Popko, B. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-γ. J. Cell Biol. 169, 603–612 (2005).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine in Neuroprotection, Neuroregeneration, and Blood–Brain Barrier Modulation: A Narrative Review;Medicina;2024-08-24

2. Remyelinating Drugs at a Crossroad: How to Improve Clinical Efficacy and Drug Screenings;Cells;2024-08-08

3. The roles of neural stem cells in myelin regeneration and repair therapy after spinal cord injury;Stem Cell Research & Therapy;2024-07-08

4. LY2940094, an NOPR antagonist, promotes oligodendrocyte generation and myelin recovery in an NOPR independent manner;Neurotherapeutics;2024-07

5. Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis;Pharmacological Reviews;2024-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3